Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amgen
Biotech
New cancer cases prompt Kyowa to shutter rocatinlimab trials
Kyowa had originally planned to seek FDA approval of the asset in atopic dermatitis in the first half of this year.
Gabrielle Masson
Mar 3, 2026 11:00am
Amgen eyes lupus redemption while cancer candidate struggles
Feb 4, 2026 6:10am
Amgen exits $400M autoimmune pact after running vast program
Jan 30, 2026 8:55am
JPM26, Day 2: Amgen touts weight loss maintenance with MariTide
Jan 13, 2026 1:30pm
Amgen dances with Disco in $618M cancer target pact
Jan 7, 2026 10:15am
Amgen weaves in UK biotech with up to $840M acquisition
Jan 6, 2026 10:35am
